123I-Iodometomidate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 123I-Iodometomidate, covering 2010-08-18 to 2010-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy [Phase 1, Phase 2]